NCT01866462View on ClinicalTrials.gov

Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Type 2 Diabetes
Interventions
OTHER

NM504

NM504 is a medical food designed to shift the dysbiota reported in type 2 diabetes. The placebo is carboxymethylcellulose prepared to look, taste and mix like NM504.

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

Sponsors

Lead Sponsor

NuMe Health
All Listed Sponsors
collaborator

Pennington Biomedical Research Center

OTHER

lead

NuMe Health

INDUSTRY

NCT01866462 - Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin | Biotech Hunter | Biotech Hunter